Skip navigation

Mitigate Compliance Risk and Improve Operational Efficiency to Streamline End-to-End Processes

October 16-17, 2019
  • Philadelphia, PA

Now in its 3rd year, CBI’s Managing HCP Interactions continues to emphasize the importance of streamlining the communication, engagement and management between the life sciences industry and HCPs. This must-attend meeting provides value-added open discussions with industry peers and proven strategies to improve the effectiveness and compliance of healthcare provider interactions.

HCP SPOTLIGHT: Tools and Tips for Industry to Partner with HCPs —
An HCP’s Perspective

Matthew Mintz, MD, FACP                     
Internal Medicine and Primary Care; Clinical Associate Professor
The George Washington University School of Medicine

BENCHMARK WITH INDUSTRY PEERS
ON CRITICAL TOPICS:

  • Establish a comprehensive and regulatory framework to successfully manage all HCP interactions
  • Examine how to identify company policies and work in
    cross-functional teams regarding thresholds/meal caps and other HCP costs
  • Brainstorm how to ease the contracting process internally
    and externally with HCPs
  • Discover real-world examples of valid FMV exceptions and the consistent use of FMV
  • Explore strategies for efficient cross-border management
  • Discuss the cultural differences to be aware of when working in multiple regions
  • Consider changes to systems, processes and policies and gain commitment from leadership ahead of specific requirements

Previous Attendee Acclaim:

Definitely a worth-while conference to attend.
Great knowledge sharing for both the
Medical Device and Pharmaceutical.

Senior Manager, Ethical Compliance, Varian Medical Systems

Valuable content overall and I learned some
useful tidbits I can use right away.

Medical Science Liaison, Vertex Pharmaceuticals

Great Information exchange!

Head of Global HCP Capabilities, Bristol-Myers Squibb

Conference was very well in level setting our understanding of the bigger picture.

Global Head, Compliance & Ethics Operations, Alexion Pharmaceuticals